A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Delray Medical Center Is First Hospital in Region Offering INSIGHTEC™

New Incisionless RX Option for Parkinson’s & Essential Tremor Patients

Delray Medical Center is the first hospital in the region to offer a new scalpel-free treatment for essential tremor and medication-refractory tremor-dominant Parkinson’s disease.

MR-guided focused ultrasound by INSIGHTEC™, uses sound wave energy to treat brain tissue at the source of the tremor.  No surgical incision or anesthesia is necessary, and patients may experience immediate and significant reduction in their hand tremors, giving them a chance to get back to their daily activities.

“This Technology Is A Game Changer In Our Community And For Those Seeking The Very Latest In Cutting Edge Technology For Neurologic Care Of Parkinson’s Disease,” Said Dr. Lloyd Zucker, Chief Of Neurosurgery At Delray Medical Center.
“This Technology Is A Game-Changer In Our Community And For Those Seeking The Very Latest In Cutting Edge Technology For Neurologic Care Of Parkinson’s Disease,” Said Dr. Lloyd Zucker, Chief Of Neurosurgery At Delray Medical Center. “The Future Is Bright For Those Who May Be Stricken With This Neurological Disease, As We Can Care For These Patients With This New Innovative Solution To Treat Tremors.”

MR-guided focused ultrasound combines two technologies, magnetic resonance imaging (MRI), which pinpoints the exact location in the brain responsible for the tremor, and ultrasound, which precisely delivers over 1,000 highly focused beams of acoustic energy at that exact location without damaging any surrounding brain tissue.

Some of the benefits to this technology include:

  • No surgical incisions resulting in reduced risk of infection.
  • Quicker recovery time with no surgical incision, allowing a return to daily activities within days.
  • Performed as an outpatient procedure – most patients go home within 23 hours.
  • Immediate and significant reduction in hand tremors.
  • Treatment has minimum side effects.

“Delray Medical Center is proud to be the first hospital in the region to offer this new technology to the community who are in need of top notch neurologic care,” said Dr. Arif Dalvi, medical director of the movement disorder center for Delray Medical Center.  “We continue to bring breakthrough treatments to our hospital so patients can find quality care close to home.”

Delray Medical Center has the advanced technology and services to help with any of your neurological issues.  As a member of the Advanced Neuroscience Network, an integrated delivery system of medical professionals and hospitals focused on offering a full continuum of neurological care throughout South Florida, we focus on everything from prevention and diagnosis to treatment and rehabilitation.  For more information about our services go to our website at www.delraymedicalctr.com or call 561-498-4440.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy